Assistant Professor of Biostatistics, Mayo Clinic. Ph.D., University of Pennsylvania. My research concerns the development and application of powerful and robust statistical methods for high-dimensional "omics" data, arising from modern high-throughput technologies such as microarray and next-generation sequencing. I am particularly interested in methods for microbiome sequencing data. Much of this effort is motivated by ongoing collaborations in projects that study the role of the human microbiome in disease pathogenesis using metagenomic sequencing.
Research interests include statistical genetics, genomics and metagenomics; and high-dimensional statistics.
I am a tenure-track Assistant Professor of Medicine and a member in Center for Computational Biology and Bioinformatics at Indiana University School of Medicine (IUSM). Before joining IUSM, I spent two years as an Assistant Professor in Harrison School of Pharmacy at Auburn University. I received a BS from China majoring in Bioinformatics in 2009; a MS in Biostatistics and another MS in Computer Science from the Johns Hopkins University in 2011 respectively. After that, I obtained my PhD in Computer Science and Informatics at Emory University in 2017. I also interned in CareerBuilder Data Science and Amazon Machine Learning in Summer 2014 and 2015 respectively.
Albert Cheng obtained his BSc in Biochemistry and MPhil in Biology from Hong Kong University of Science and Technology in 2005 and 2007, respectively. He studied neurotrophin signaling and C. elegans developmental genetics. He then pursued his PhD in Computational & Systems Biology at MIT in the labs of Profs Christopher Burge and Rudolf Jaenisch and worked on various topics on epigenetics, gene regulation and alternative splicing in stem cells, reprogramming, cancer metastasis, erythropoiesis and differentiation. Cheng and colleagues identified H3K27ac as a signature for active enhancers. He analyzed alternative splicing in epithetlial-mesenchymal transition, cancer metastasis as well as erythropoiesis and identified splicing factors regulating these processes. He constructed CRISPR-on, an artificial RNA-guided activator based on CRISPR/Cas. After graduating in 2014, he joined the Jackson Laboratory at Bar Harbor, ME, as one of the first JAX scholars where he continued to work on understanding and improving the CRISPR/Cas technology. In July 2015, he started his own lab as an assistant professor at the Jackson Laboratory for Genomic Medicine campus at Farmington, CT.
Professor of the Department of Plant Science and Director of Plant Genomics and Breeding Institute of Seoul National University, Korea
Constance Ciaudo has been Assistant Professor of RNAi and Genome Integrity at the Institute of Molecular Health Science at ETH Zurich since April 2013. She obtained her PhD degree in 2006 at the Pasteur Institute in Paris, France After four years as a postdoctoral fellow at the Curie Institute in Paris, supervised by Prof. Edith Heard and at the Institute of Plant Biology (IBMP) in Strasbourg, France, supervised by Prof. Olivier Voinnet, she worked from 2010-2013 at ETH Zurich, Switzerland.
Giuseppina obtained her MSc in Cellular and Molecular Biology in 2009 at the University of Rome Tor Vergata, Italy. After spending two years in the laboratory of Prof. Susanna Dolci (Tor Vergata Faculty of Medicine, Rome), she moved to Milan in the laboratory of Prof. Pier Paolo Di Fiore (IFOM-IEO Institute ).
During this time she worked on the generation of a c-Kit transgenic mouse model and regulation of spermatogenesis, 3D cell cultivation and characterization of stem cells from murine breast and prostate tissue and breast biopsy.
She graduated in 2015 at the SBP Graduate School of Biomedical Science; La Jolla, CA, USA. under the supevision of Prof. Ze'ev Ronai. She extended her training in the Ronai's laboratory until December 2016, During this time she worked on prostate cancer and melanoma using cell lines and murine models. She gained experience in transcription regulation, splicing and mouse pathology.
Currently, under the mentorsip of Prof. Caroline Robert and Dr. Stéphan Vagner, she is working at the Gustave Roussy Institute. Her studies are focused on metabolism and translation regulation in melanoma biology.
Emmy Noether research group leader, Albert-Ludwigs-Universität Freiburg, Germany
Emmy Noether research group leader, Ludwig Maximilians University, Munich, Germany
Postdoc, Department of Molecular and Cell Biology, UC Berkeley, USA
PhD in Biology, Max Planck Institute of Molecular Cell Biology and Genetics Dresden, Germany
Wallace Renard Professor of Psychiatry; Professor of Genetics and Psychology; Director of Sansone Family Center for Well-Being; of Washington University School of Medicine.
Full Professor and former Chair of the Department of Biological Sciences at Florida International University. Director of FIU DNA Core facility. Past Program Director for NSF Division of Environmental Biology, Systematics and Biodiversity Cluster.
Research interests include: Molecular Systematics, Evolution, Biogeography, and Phylogeography: Rates, patterns, and mechanisms of molecular evolution , including nucleotide sequence evolution and mitochondrial gene order change, and consequences for phylogenetic reconstruction and reconstruction of ancestral states. Integration of molecular data with paleontological and morphological data. Using phylogenies to address biological questions.
I was a post-doc in the group of Jonathan Pritchard in the Department of Human Genetics, University of Chicago, while there I also work closely with Molly Przeworski. Before that I was a PhD student with Bob Griffiths in the mathematical genetics group in Statistics Department at Oxford. I’m now an associate professor in the Department of Evolution and Ecology at UC Davis.
Senior Lecturer in Biological Sciences at the University of Huddersfield, since 2015. Previously Junior Research Fellow, College Lecturer In Biochemistry and various postdocs at the University of Oxford (2013-15). Working on DNA replication, genome integrity and transcription factors in human cancers (and also in prokaryotes). Additional interests in phylogenomics and novel protein expression systems.